GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » 12-1 Month Momentum %

TalkMed Group (SGX:5G3) 12-1 Month Momentum % : 4.94% (As of May. 15, 2024)


View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-15), TalkMed Group's 12-1 Month Momentum % is 4.94%.

The industry rank for TalkMed Group's 12-1 Month Momentum % or its related term are showing as below:

SGX:5G3's 12-1 Month Momentum % is ranked better than
65.74% of 648 companies
in the Healthcare Providers & Services industry
Industry Median: -11.695 vs SGX:5G3: 4.94

Competitive Comparison of TalkMed Group's 12-1 Month Momentum %

For the Medical Care Facilities subindustry, TalkMed Group's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TalkMed Group's 12-1 Month Momentum % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where TalkMed Group's 12-1 Month Momentum % falls into.



TalkMed Group  (SGX:5G3) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TalkMed Group  (SGX:5G3) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


TalkMed Group 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of TalkMed Group's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


TalkMed Group (SGX:5G3) Business Description

Traded in Other Exchanges
N/A
Address
3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510
TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group (SGX:5G3) Headlines

No Headlines